Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,062 | 47,652 | 53,076 | 61,428 | 69,804 |
| TOTAL | $40,463 | $50,045 | $56,584 | $62,179 | $71,298 |
| Non-Current Assets | |||||
| PPE Net | 20 | 21 | 24 | 27 | 31 |
| Other Non-Current Assets | 200 | 272 | 215 | 278 | 220 |
| TOTAL | $221 | $292 | $239 | $306 | $251 |
| Total Assets | $40,684 | $50,337 | $56,824 | $62,485 | $71,550 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,990 | 1,988 | 1,773 | 2,548 | 2,361 |
| Accrued Expenses | 3,505 | 4,513 | 5,353 | 6,267 | 8,038 |
| TOTAL | $7,684 | $6,720 | $7,317 | $9,040 | $10,598 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 68,778 | 28 | 0 | 30 | 0 |
| TOTAL | $68,778 | $28 | $N/A | $30 | $N/A |
| Total Liabilities | $76,462 | $6,748 | $7,317 | $9,070 | $10,598 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,170 | 1,099 | 1,099 | 1,073 | 1,059 |
| Common Shares | 23 | 22 | 1 | 21 | 21 |
| Retained earnings | -287,330 | -189,071 | -181,134 | -173,379 | -163,927 |
| Other shareholders' equity | -10,267 | -10,425 | -10,359 | -10,455 | -10,247 |
| TOTAL | $-35,778 | $43,589 | $49,507 | $53,415 | $60,952 |
| Total Liabilities And Equity | $40,684 | $50,337 | $56,824 | $62,485 | $71,550 |